These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21565479)

  • 61. Treatment implication from the potential association between nonalcoholic fatty liver disease and cardiovascular disease.
    Shen L
    Hepatology; 2011 Jul; 54(1):377-8. PubMed ID: 21710476
    [No Abstract]   [Full Text] [Related]  

  • 62. [Obesity and metabolic syndrome in children and adolescents].
    Rosende A; Pellegrini C; Iglesias R
    Medicina (B Aires); 2013; 73(5):470-81. PubMed ID: 24152409
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cardiovascular risk in children and adolescents with type 2 diabetes mellitus.
    Prendergast C; Gidding SS
    Curr Diab Rep; 2014 Feb; 14(2):454. PubMed ID: 24402326
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metabolic syndrome in children and adolescents: Old concepts in a young population.
    Titmuss AT; Srinivasan S
    J Paediatr Child Health; 2016 Oct; 52(10):928-934. PubMed ID: 27301065
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Algorithm of diagnosis and treatment of metabolic syndrome].
    Mamedov MN
    Kardiologiia; 2005; 45(5):92-100. PubMed ID: 16007064
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations.
    Mameli C; Zuccotti GV; Carnovale C; Galli E; Nannini P; Cervia D; Perrotta C
    Pharmacol Res; 2017 May; 119():99-117. PubMed ID: 28111263
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metabolic syndrome in children and adolescents: prevalence, public health issue, and time for initiative.
    Kiess W; Blüher S; Kapellen T; Körner A
    J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):268-71. PubMed ID: 19590451
    [No Abstract]   [Full Text] [Related]  

  • 68. [Lifestyle related diseases in children and adolescents].
    Ohki Y; Kishi M
    J Nippon Med Sch; 2001 Apr; 68(2):190-3. PubMed ID: 11301366
    [No Abstract]   [Full Text] [Related]  

  • 69. [Treatment of obese children and adolescents--necessity and options].
    Chen-Stute A
    MMW Fortschr Med; 2004 Oct; 146(41):28-9, 31-2. PubMed ID: 15532734
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Type 2 diabetes mellitus in pediatrics: a new challenge.
    Van Name M; Santoro N
    World J Pediatr; 2013 Nov; 9(4):293-9. PubMed ID: 24235062
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metabolic syndrome - A truly psychosomatic disorder? A global hypothesis.
    Ghike SM
    Med Hypotheses; 2016 Dec; 97():46-53. PubMed ID: 27876129
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative aspects of rodent and nonrodent animal models for mechanistic and translational diabetes research.
    Renner S; Dobenecker B; Blutke A; Zöls S; Wanke R; Ritzmann M; Wolf E
    Theriogenology; 2016 Jul; 86(1):406-21. PubMed ID: 27180329
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lifestyle and Pharmacological Interventions and Treatment Indications for the Management of Obesity in Children and Adolescents.
    Herouvi D; Paltoglou G; Soldatou A; Kalpia C; Karanasios S; Karavanaki K
    Children (Basel); 2023 Jul; 10(7):. PubMed ID: 37508727
    [TBL] [Abstract][Full Text] [Related]  

  • 74. NAFLD-the next global epidemic.
    Ray K
    Nat Rev Gastroenterol Hepatol; 2013 Nov; 10(11):621. PubMed ID: 24185985
    [No Abstract]   [Full Text] [Related]  

  • 75. [Therapy of metabolic syndrome].
    Magyar Diabetes Társaság Metabolikus Munkacsoportja
    Orv Hetil; 2003 Jun; 144(23):1145-52. PubMed ID: 12858647
    [No Abstract]   [Full Text] [Related]  

  • 76. Metformin: Expanding the Scope of Application-Starting Earlier than Yesterday, Canceling Later.
    Kononova YA; Likhonosov NP; Babenko AY
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216477
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Polymorphisms of Fat Mass and Obesity-Associated Gene in the Pathogenesis of Child and Adolescent Metabolic Syndrome.
    Song Y; Wade H; Zhang B; Xu W; Wu R; Li S; Su Q
    Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375547
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence and Predictive Clinical Characteristics of Metabolically Healthy Obesity in Obese Children and Adolescents.
    Dundar I; Akinci A
    Cureus; 2023 Mar; 15(3):e35935. PubMed ID: 37038589
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of Mediterranean diet on inflammatory biomarkers and components of metabolic syndrome in adolescent girls.
    Asoudeh F; Fallah M; Aminianfar A; Djafarian K; Shirzad N; Clark CCT; Larijani B; Esmaillzadeh A
    J Endocrinol Invest; 2023 Oct; 46(10):1995-2004. PubMed ID: 36795242
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis.
    Lu Z; Li Y; Li AJ; Syn WK; Wank SA; Lopes-Virella MF; Huang Y
    PLoS One; 2022; 17(11):e0277251. PubMed ID: 36331958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.